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Abstract Experimental autoimmune encephalomyelitis
(EAE) is an autoimmune demyelinating disease that can
be induced in a variety of animal species and which is
commonly used as an animal model of multiple sclerosis.
In rodent EAE models, the clinical disease is typified by
ascending paralysis; however, other clinical patterns can
also be observed by inducing disease with particular pep-
tides of myelin proteolipid protein (PLP) or myelin oligo-
dendrocyte glycoprotein. Here we describe EAE induced
in C3H/HeJ mice by inoculation with residues 190–209 of
PLP. This form of EAE is manifested clinically by a
movement disorder, with axial rotation of the head and
trunk. Histologically, this form of EAE is characterized by
predominant cerebellar or brain stem involvement, de-
pending on whether EAE is induced by active immuniza-
tion with the PLP peptide, or by passive transfer of T cells
specific for the peptide. The inflammatory cell infiltrate is
composed of polymorphonuclear cells and mononuclear
cells. This rotatory form of EAE may be a useful model
for studying the neuropathological characteristics of mul-
tiple sclerosis affecting the brain stem and cerebellum.
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Introduction
Experimental autoimmune encephalomyelitis (EAE) is an
autoimmune disease of the nervous system which is
widely studied as an animal model of the human demyeli-
nating disease multiple sclerosis (MS) [26]. EAE can be
induced by inoculation with an emulsion of whole spinal
cord or brain, or whole or part of a myelin protein, in ad-
juvant (active EAE). For induction of EAE in mice, Bor-
detella pertussis toxin is often injected concurrently [9,
20, 21]. In passively induced EAE, T cells specific for
myelin proteins are injected, with or without pertussis
toxin. The most commonly used myelin proteins for the
induction of EAE are myelin basic protein (MBP), which
has been studied extensively (reviewed in [38]), myelin
proteolipid protein (PLP) [9, 11, 34] and myelin oligoden-
drocyte glycoprotein (MOG) [2, 15, 16]. Immunization
with MBP results in demyelinated lesions in both the CNS
and peripheral nervous system (PNS) [1, 4, 5, 25, 27, 28],
whereas EAE induced by PLP or MOG results in de-
myelinated lesions that are restricted to the central ner-
vous system (CNS) [2, 4, 5, 9, 16].
The characteristic clinical feature of EAE in mice and
rats is ascending paralysis, commencing at the distal end
of the tail and moving rostrally to affect the whole tail,
hindlimbs and sometimes the forelimbs [6, 9, 17, 23, 31].
In these forms of EAE (ascending paralysis EAE), neu-
ropathological analyses typically show that the CNS in-
flammatory and demyelinating lesions are located pre-
dominantly in the spinal cord [6, 24, 25, 31, 33].
However, clinical signs other than ascending paralysis
have also been described in some strains of mice when
EAE is induced by PLP or MOG. In most strain/antigen
combinations, the development of these atypical signs is
not consistent, e.g., EAE induced in PL/J mice by MOG
peptides [16] or in BALB/c mice by PLP178–191 [11] can
cause forelimb paralysis in the absence of hindlimb paral-
ysis or tail paralysis, and disturbances of balance in some
animals, but the clinical signs vary from one animal to an-
other.
CBA/J or C3H/HeJ mice immunized with PLP190–209 or
PLP215–232 also develop an unusual form of EAE, but the
clinical features of this form of EAE are reproducible in
the majority of mice and always follow the same pattern.
The initial neurological abnormality is the turning of the
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head to one side. This head turning becomes more pro-
nounced until at the most severe stage of disease the ani-
mal can not stand upright and rolls with an axial rotatory
movement (rotatory EAE) [11].
The present study was undertaken to explore further
the features of axial rotatory EAE induced by PLP190–209
in C3H/HeJ mice and to determine the neuropathological
lesion distribution in mice showing these clinical signs.
Firstly, we compared the clinical signs of actively versus
passively induced disease. Next, we undertook a detailed
histological analysis to elucidate the specific neural struc-
tures that are affected and to correlate the histopathology
with the clinical neurological deficits. We report that mice
that develop rotatory clinical signs have an increased con-
centration of inflammatory and demyelinated lesions
within the brain stem and/or cerebellum, compared to
mice that develop ascending paralysis. We also show that
the distribution of lesions in rotatory EAE differs depend-
ing on whether EAE is induced by active immunization
with PLP peptide or by passive transfer of T cells specific
for the peptide. This rotatory EAE model will be useful
for studying the neuropathological features of MS, particu-
larly in those patients who have cerebellar and/or brain
stem lesions.
Materials and methods
Mice
Female C3H/HeJ mice were purchased from the Animal Resources
Centre, Perth, Western Australia. Mice were immunized at 8–10
weeks of age. All animals were maintained in accordance with the
guidelines of the National Health and Medical Research Council of
Australia.
PLP peptides
PLP peptide 190–209 (SKTSASIGSLCADARMYGVL) was syn-
thesized by Auspep (Melbourne, Australia) according to the hu-
man sequence [13] and was greater than 95% pure by high perfor-
mance liquid chromatography (HPLC) and mass spectral analysis.
This peptide is moderately hydrophobic and was dissolved at a
concentration of 5 mg/ml in 0.2 M acetic acid prior to dilution in
phosphate-buffered saline (PBS) or tissue culture medium.
Active induction of EAE
Mice were injected subcutaneously in the flank with 100 m g
PLP190–209 peptide and 400 m g Mycobacterium tuberculosis H37Ra
(Difco Laboratories, Detroit) in an emulsion with complete Fre-
und’s adjuvant (CFA, Difco). The mice also received 300 ng per-
tussis toxin (List Biological Laboratories, Campbell, California)
intravenously at the same time as the peptide and again 3 days
later.
PLP190–209-specific T cell lines
Mice were injected subcutaneously with 100 m g PLP190–209 emulsi-
fied in CFA. After 10 days the inguinal and axillary lymph nodes
were removed and stimulated with PLP190–209. The T cell lines
were maintained in RPMI 1640 containing 10% fetal calf serum, 2
mM L-glutamine, 10 mM HEPES buffer and 50 m M 2-mercap-
toethanol, and stimulated every 10–15 days with 5–10 m g/ml of the
peptide using irradiated (2500 rad) spleen cells as antigen-present-
ing cells.
Passive induction of EAE
After T cells had been stimulated in vitro four to five times, cells
were harvested, the T cell blasts separated on a Ficoll gradient and
washed. Five million to 10 million T cells specific for PLP190–209
were injected intravenously into naïve C3H/HeJ mice. Some of the
animals were also immunized intravenously with 300 ng pertussis
toxin at the same time as the T cells and again 3 days later.
Clinical evaluation
Mice were weighed daily and assessed for clinical signs of EAE.
Signs of ascending paralysis EAE were scored according to the
following criteria: 0, no disease; 1, decreased tail tone or slightly
clumsy gait; 2, tail atony and/or moderately clumsy gait and/or
poor righting ability; 3, limb weakness; 4, limb paralysis; 5, mori-
bund state. Signs of rotatory EAE were assessed as previously de-
scribed [11]; 0, no disease; 1, head turned slightly; 2, head turning
more pronounced; 3, inability to walk in a straight line; 4, laying
on side; 5, rolling continuously unless supported. Animals were
killed at the peak of disease.
Histological evaluation
Animals were perfused with modified Karnovsky’s fixative (2.0%
paraformaldehyde, 2.5% glutaraldehyde, 2 mM CaCl2, 0.1 M ca-
codylate buffer pH 7.3), and the brain, optic nerves, spinal cord
and cauda equina were removed. Tissue was post-fixed in Dalton’s
solution and embedded in Historesin (Leica Instruments, Heidel-
berg). Resin blocks were sectioned (1 m m) in the transverse plain
every 25 m m and stained with cresyl fast violet [22]. Sections were
examined for inflammatory lesions and demyelination at all levels
of the CNS. Inflammation, rather than demyelination, was quanti-
fied, as the boundaries of inflammation were easily identified,
whereas the exact extent of demyelination was often obscured by
the presence of inflammatory cells. The size of the inflammatory
lesions within these sections was also determined with an eyepiece
graticule (10 · 10 grid), using a method similar to that employed
by Vass et al. [36]. By moving the eyepiece graticule over each
section in both the x and y planes measuring each area only once
and counting the number of squares containing tissue in each area,
the number of squares equivalent to the entire sectional area was
calculated. To increase accuracy each square was subdivided into
eight, and if one square was not completely filled by tissue, the
number of one eighths of the square that were filled with tissue
was added to the number of whole squares. This process was re-
peated, counting only the squares containing inflammatory lesions
to calculate the percentage of lesions within each tissue section.
The results of analyses were grouped for specific areas of the
CNS, based on the general pattern of lesions. An atlas of the
mouse brain [8] was used to assist in the identification of anatom-
ical structures. Area 1 extended from the optic nerve to the rostral
appearance of the superior colliculus; area 2 extended from the su-
perior colliculus to the rostral appearance of the sensory root of the
trigeminal nerve; area 3 extended from the rostral appearance of
the vestibular root of the vestibular nerve to the caudal termination
of the facial nerve; area 4 extended from the caudal appearance of
the vestibulocochlear nerve to the caudal termination of the trape-
zoid body; area 5 extended from the rostral appearance of the
spinal trigeminal nuclei, interpolar, to the pyramidal decussation;
area 6 comprised the entire cerebellum; area 7 extended from C1 to
C8 of the spinal cord; area 8 extended from T1–T13; area 9 ex-
tended from L1 to L6; and area 10 extended from S1 to S4. The
cauda equina was examined separately for possible PNS involve-
ment.
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Statistics
To assess statistical differences in lesional area at similar anatom-
ical levels among groups of animals, an F test for analysis of vari-
ance was performed and, based on the results of this test, Student’s
t-test was performed. For each anatomical level of each animal, a
section was analyzed every 100 m m. Thus, for each anatomical
level, 36–48 sections were analyzed. Each section was included as
a separate data point in the analysis of variance and the t-test. Re-
sults with a recorded P value of less than or equal to 0.05 were
considered statistically significant.
Results
Clinical observations
Table 1 shows, for each mouse tested, the method of in-
duction of EAE, the day of onset of clinical signs of dis-
ease, the clinical score at the peak of disease, and the clin-
ical features at the peak of disease. For animals that were
perfused for histological analysis, the day on which they
were perfused is also shown.
EAE was actively induced in 7 C3H/HeJ mice. All of
these animals developed rotatory clinical signs, with no
signs of weakness in any limbs or in the tail. The mean
day of onset of clinical signs was 17.1 ± 6.7 days, and the
mean clinical score was 4.2 ± 0.4. Onset of rotatory EAE
was very rapid, with most mice changing from a normal
clinical appearance to a score of 4 or 5 within 12 h.
Of the animals with passively induced EAE, 10 of 14
(71%) developed rotatory clinical signs with a mean day
of onset (17.4 ± 7.1) and mean clinical score (4.6 ± 0.5)
similar to those of mice with actively induced EAE. None
of these animals showed signs of weakness in any limbs
or in the tail. The other 4 mice with passively induced
EAE developed clinical signs of ascending paralysis, i.e.,
signs of tail, hindlimb and forelimb weakness or paralysis.
However, 1–2 days prior to the onset of these clinical
signs, all showed signs of head turning slightly to one
side. The head turning was no longer apparent upon de-
velopment of signs of ascending paralysis. These 4 mice
had an increased mean day of onset of EAE (25.5 ± 11.9)
compared to animals that developed rotatory clinical signs
but this difference was not significant (P = 0.359). Ad-
ministration of pertussis toxin did not have a significant
influence on the type of clinical signs that subsequently
developed.
CNS tissues from 11 of the mice (Table 1) were subse-
quently studied by histological analysis. Mice that were
not used for histological analysis were followed for up to
300 days after immunization. All these animals sponta-
neously relapsed, but the length of time between relapses
varied from 10 to 30 days, and the clinical signs exhibited
during relapses ranged from tail and/or limb paralysis to
pronounced head turning and axial rotation.
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Table 1 Immunization protocol and clinical findings of C3H/HeJ mice. Different scoring systems were used for rotatory and ascending
paralysis EAE (see Materials and methods). Not all mice were used in subsequent histological analysis (EAE experimental autoimmune
encephalomyelitis)
Method of EAE Pertussis Day of Clinical score at Clinical signs at Histological Day perfused
induction toxin onset peak of disease peak of disease analysis (peak of disease)
Active + 21 4.5 Rotatory
+ 31 5 Rotatory + 31
+ 10 4 Rotatory + 13
+ 11 4 Rotatory + 11
+ 13 4 Rotatory + 13
+ 17 4 Rotatory
+ 17 4 Rotatory
Mean ± SD 17.1 ± 6.7 4.2 ± 0.4
Passive + 11 5 Rotatory + 11
+ 36 4 Rotatory
– 11 5 Rotatory + 11
– 11 5 Rotatory + 12
– 18 5 Rotatory + 29
– 19 4 Rotatory
– 17 5 Rotatory
– 14 4 Rotatory
– 21 4 Rotatory
– 16 5 Rotatory
Mean ± SD 17.4 ± 7.1 4.6 ± 0.5
+ 11 4 Ascending paralysis + 12
+ 42 4 Ascending paralysis + 51
– 31 4 Ascending paralysis + 35
– 18 4 Ascending paralysis
Mean ± SD 25.5 ± 11.9 4.0
Histological analyses
Tables 2 and 3 outline the average percentages of the
transverse sectional area that were inflamed at each level
of the CNS in each group of animals.
In all animals, the inflammatory lesions were com-
posed of polymorphonuclear cells and mononuclear cells.
The polymorphonuclear cells predominated in the early
stages of lesion development (Fig.1A), whereas mononu-
clear cells predominated in established demyelinated le-
sions (Fig.1B). The administration of pertussis toxin did
not influence the cellular composition of inflammatory in-
filtrates. Inflammation was not restricted to areas of de-
myelination; however, the majority of inflammatory le-
sions did contain large numbers of demyelinated axons
(Fig.2). In general, axons and nerve cell bodies were pre-
served but there was some evidence of axonal degenera-
tion (Wallerian degeneration) in the dorsal columns of an-
imals with spinal cord lesions and also in the brain stems
of some animals (Fig.3).
Histological analyses of the CNS of C3H/HeJ mice
from each group revealed a different spatial distribution
of lesions in the mice with rotatory EAE compared to as-
cending paralysis EAE (Table 2, Fig. 4) and in mice with
passively induced rotatory EAE compared to actively in-
duced rotatory EAE (Table 3, Fig.4), as described below.
Cerebrum (area 1)
There was limited inflammation and demyelination in the
cerebrum in all three groups (Tables 2, 3). Subpial infil-
trates were observed surrounding the cerebrum, the optic
chiasm and optic tract. In most animals there was also in-
flammation and demyelination in the parenchyma affect-
ing the fibers of the optic chiasm and optic tracts.
Brain stem (areas 2–5)
The extent of lesions in the brain stem differed consider-
ably among groups, but the vestibulocochlear nerve root
entry zone was generally the most severely affected re-
gion (Fig. 1B). Animals with rotatory EAE had signifi-
cantly more lesions within areas 2–5 in the brain stem,
compared to animals with ascending paralysis EAE 
(P < 0.01) (Table 2). In animals with passively induced
rotatory EAE, the brain stem was the major site of in-
volvement (Table 3).
In the animals with passively induced rotatory EAE,
lesions spanned the area from the brachium pontis along
the ventrolateral white matter tracts of the brain stem to
the lower medulla to give the appearance of an elongated
confluent lesion. In the midbrain (area 2), the average area
of inflammation within sections was 7.9% (maximum
27%). The brachium pontis, cerebral peduncle, middle
cerebellar peduncle and the motor root of the trigeminal
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Table 2 Comparison of extent of inflammation in different anatomical areas of animals with rotatory or ascending paralysis EAE. The
anatomical areas of the CNS designated 1–10 are described in detail in the Materials and methods section. Values represent mean ± SD
of the percentages of the transverse sectional area affected by inflammatory lesions (see Materials and methods)
Clinical Anatomical areaa
signs
1 2 3 4 5 6 7 8 9 10
Cerebrum Midbrain Pons Upper Lower Cerebellum Cervical Thoracic Lumbar Sacral 
medulla medulla cord cord cord cord
Rotatory 0.8 ± 0.9a 5.8 ± 8.5a 5.1 ± 5.0a 1.0 ± 1.4a 1.6 ± 1.5a 2.8 ± 3.2a 0.2 ± 0.4 0.2 ± 0.5 1.0 ± 2.2 6.7 ± 7.5
Ascending 0.1 ± 0.1 0.1 ± 0.1 0.2 ± 0.2 0.0 ± 0.1 0.4 ± 0.6 0 0.2 ± 0.5 7.8 ± 6.1b 23.7 ± 9.4b 36.2 ± 4.8b
paralysis
a The percentage of transverse sectional area affected by inflam-
matory lesions in mice with rotatory forms of EAE is significantly
greater than in mice with ascending paralysis EAE (P < 0.01)
b The percentage of transverse sectional area affected by inflam-
matory lesions in mice with ascending paralysis EAE is signifi-
cantly greater than in mice with rotatory forms of EAE (P < 0.001)
Table 3 Comparison of extent of inflammation in different anatomical areas of animals with rotatory EAE induced by either active or
passive means. Values represent mean ± SD of the percentages of the transverse sectional area affected by inflammatory lesions
Method Anatomical area
of EAE
induction 1 2 3 4 5 6 7 8 9 10
Cerebrum Midbrain Pons Upper Lower Cerebellum Cervical Thoracic Lumbar Sacral 
medulla medulla cord cord cord cord
Active 0.4 ± 0.8 1.6 ± 0.6 0.8 ± 0.4 0 1.1 ±1.4 5.5 ± 2.2a 0 0 1.1 ± 1.4 7.3 ± 2.7
Passive 0.8 ± 0.9 7.9 ± 9.8b 7.2 ± 4.9b 1.6 ± 1.5b 1.8 ± 1.6 0 0.3 ± 0.4b 0.2 ± 0.6b 0.9 ± 2.6 6.4 ± 9.0
a The percentage of transverse sectional area affected by inflam-
matory lesions is significantly greater in mice with actively in-
duced rotatory EAE than in mice with passively induced rotatory
EAE (P < 0.001)
b The percentage of transverse sectional area affected by inflam-
matory lesions in mice with passively induced rotatory EAE is sig-
nificantly greater than in mice with actively induced rotatory EAE
(P < 0.05)
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nerve were affected. In the pons (area 3), the sensory root
of the trigeminal nerve, ventral spinocerebellar tract,
vestibular root of the vestibulochlear nerve and the an-
teroventral cochlear nuclei were also inflamed. The sever-
ity of the inflammation and demyelination increased cau-
dally, affecting the vestibulocochlear nerve, trapezoid body,
facial nerve and its root, olivocochlear bundle, spinal
trigeminal tract, middle cerebellar peduncle, and the ven-
tral cochlear nuclei. The lesions affected up to 19% of the
transverse sectional area at this level with the average be-
ing 7.2%. In the upper medulla (area 4), the inferior cere-
bellar peduncle, vestibular nerve, and the spinal trigemi-
nal tract were inflamed (average of 1.6% of the total sec-
tion area). In addition, the central tissue projections of
both the accessory and the hypoglossal nerves were in-
flamed and demyelinated. At the lower medulla (area 5),
white matter adjacent to the area postrema was inflamed
(average area of inflammation of 1.8%).
Analysis of the CNS of animals with actively induced
rotatory EAE or passively induced ascending paralysis
EAE also showed inflammation and demyelination affect-
ing some of the same structures within the brain stem as
described for passively induced rotatory EAE, particularly
the vestibulocochlear nerve root entry zone, trigeminal
nerve and the cerebellar peduncles. However, the lesions
were less extensive than those observed in passively in-
duced rotatory EAE, with an average area of inflamma-
tion in the brain stem ranging from 0% to 1.6% of the to-
tal transverse section (Tables 2, 3).
Cerebellum (area 6)
None of the mice with passively induced EAE showed
any lesions in the cerebellum, regardless of their pattern
of clinical signs (Tables 2, 3). In contrast, all animals with
actively induced rotatory EAE had severe inflammatory
and demyelinated lesions in the cerebellar white matter of
all cerebellar lobules, particularly the fourth and fifth lob-
Fig.1 A Cellular infiltrate consisting predominantly of polymor-
phonuclear cells (arrows) in the lumbar spinal cord of a mouse
with passively induced ascending paralysis EAE. B Mononuclear
cells present in an established demyelinated lesion involving the
vestibulocochlear nerve root entry zone in the pons of a mouse
with passively induced rotatory EAE. Demyelinated axons are in-
dicated by arrows (EAE experimental autoimmune encephalo-
myelitis). Cresyl fast violet, bars 25 m m
Fig.2 Selective inflammation and demyelination of myelinated
nerve fibers of the CNS (arrow) in the central tissue projection of
the dorsal root entry zone of the sacral spinal cord of a mouse with
passively induced ascending paralysis EAE. The myelinated fibers
of the PNS (arrowhead) are not affected. Cresyl fast violet, bar
25 m m
Fig.3 Wallerian degeneration in vestibular pathway in the pons of
a mouse with passively induced rotatory EAE. Cresyl fast violet,
bar 25 m m
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ules, the flocculus, paraflocculus, and cerebellar commis-
sure (Table 3). In most cases the inflammation was
perivascular, extending into the parenchyma, and, in some
instances, forming confluent lesions (Fig.5). The maxi-
mum area of inflammation in these animals covered 11%
of a transverse cerebellar section.
Spinal cord (areas 7–10)
The extent of spinal cord lesions in each group of mice in-
creased caudally. The animals with rotatory EAE showed
significantly less inflammation in the thoracic, lumbar
and sacral spinal cord compared to animals with ascend-
ing paralysis EAE (P < 0.001).
In animals with ascending paralysis EAE (Table 2), in-
flammation and demyelination were present in the dorsal
root entry zones and ventral root exit zones throughout the
entire spinal cord. There was inflammation and primary
demyelination in the dorsal columns. In addition there
was collapse or dilatation of many myelin sheaths in the
dorsal columns, indicating axonal degeneration. The cer-
vical spinal cord (area 7) was the least affected area, but
the extent of lesions increased markedly in the thoracic
spinal cord, with some sections showing inflammation
and demyelination across the entire dorsal and/or ventral
surface of the spinal cord. The average area of inflamma-
tion per transverse section at the thoracic level was 7.8%.
The lumbar and sacral spinal cord showed severe conflu-
ent inflammation and demyelination encompassing al-
most all nerve fibre tracts. The average areas of inflam-
mation in the lumbar and sacral spinal cord were 23.7%
and 36.2%, respectively. Lesions affected up to 51% of
the transverse sectional area in sacral spinal cord sections.
Mice with rotatory EAE had very few lesions in the
cervical and thoracic spinal cord. On average, less than
0.5% of the total section area was inflamed at any given
level, and any lesions that were present were restricted to
either the root entry/exit zones (the central tissue projec-
tion being most severely affected), or the dorsal columns.
The dorsal columns of the rostral spinal cord segments
also contained some collapsed or dilated myelin sheaths.
Lesions in the lumbar and sacral cord were also concen-
trated around the root entry/exit zones, but some conflu-
ent lesions affecting all superficial surfaces also occurred
in these animals. In the lumbar cord the mean transverse
sectional area encompassed by lesions was 1.0% in rota-
tory EAE. In the sacral cord this percentage rose to 6.7%
(Table 2).
Examination of the cauda equina revealed that there
were no inflammatory or demyelinated lesions in the
spinal roots of the PNS.
Discussion
This study demonstrates that a form of EAE, induced by
injection of PLP190–209 or T cells specific for this peptide,
and characterized clinically by axial rotation, shows sig-
nificant histological differences from the ascending paral-
ysis form of murine EAE. The major sites of inflamma-
tory and demyelinated lesions in mice with severe axial
rotation were the cerebellum and brain stem, depending
upon whether EAE was actively or passively induced, re-
spectively. In contrast, mice that developed ascending
paralysis EAE had the greatest concentration of lesions in
the spinal cord, especially in the lumbosacral regions, as
has previously been reported for ascending paralysis
forms of EAE [6, 24, 31, 33].
The axial rotation observed in the mice is most likely
due to involvement of the vestibular pathways in the brain
stem and/or cerebellum. The clinical deficits could be ex-
plained either by primary demyelination and/or axonal de-
generation of the primary sensory neurons of the vestibu-
lar nerve in the CNS or by damage in a postsynaptic path-
way between the vestibular nuclei and the cerebellum,
e.g., inferior cerebellar peduncle. Only one other study of
EAE in mice has reported clinical signs similar to those in
our study. Endoh et al. [7] observed axial rotation in
BALB/cCr mice after induction of EAE with DM20, an
alternatively spliced isoform of PLP; however, they re-
ported that lesions within the brain stem and cerebellum
were uncommon. In the BALB/cCr mice, loss of tail tone
always preceded the axial rotation, whereas in our study
the loss of balance resulting in rotatory movements was
the first sign of EAE and occurred in the absence of tail or
limb weakness.
The cellular composition of the inflammatory infil-
trates in C3H/HeJ mice with EAE is of interest, in that
polymorphonuclear cells made up a large percentage of
the cells infiltrating the parenchyma in the early lesions.
This is similar to that seen in hyperacute EAE in the
Lewis rat, where there is a major neutrophilic infiltrate
[19], and to that reported in early EAE studies in mice
[29]. The abundance of polymorphonuclear cells in the in-
filtrate in C3H/HeJ mice could be due to different pro-in-
flammatory cytokines/chemokines being induced in dif-
ferent mouse strains. Alternatively, it could be a matter of
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Fig.5 Inflammation in the cerebellum of a mouse with actively
induced rotatory EAE. Cresyl fast violet, bar 50 m m
timing. In normal inflammatory responses, polymorpho-
nuclear cells and mononuclear cells are rapidly attracted
to the site of inflammation; however, the polymorphonu-
clear cells are lost from the site within 24–48 h, whereas
the mononuclear cells persist [14]. Because of the rapid
onset of clinical signs in the mice used in the current
study, most mice were studied histologically on the day of
onset of clinical signs and may, therefore, have been more
likely to have polymorphonuclear cell infiltrates.
There are several possible explanations for the relative
restriction of lesions to the brain stem and cerebellum in
C3H/HeJ mice that developed rotatory clinical signs. One
possibility is that the target antigen, PLP190–209, varies in
its distribution or accessibility within the CNS. Although
it is known that PLP is distributed throughout CNS
myelin, there is evidence that oligodendrocytes that
myelinate different regions of the CNS can originate at
different times during development [32] and that the bio-
chemical and physical properties of oligodendrocytes dif-
fer, depending on where they are situated in the CNS [3,
18]. Another possibility is that the C3H/HeJ strain of mice
differs from other strains in the concentration of profes-
sional antigen-presenting cells or in the expression of ma-
jor histocompatibility complex molecules in certain areas.
If the antigen (PLP190–209) were more successfully
processed or presented to T cells entering the CNS in a
particular area, there could be increased inflammation in
that area. These possibilities are currently being investi-
gated. It seems unlikely that the relative restriction of le-
sions is due to increased permeability of the blood-brain
barrier of the brain stem and cerebellum of these mice,
particularly in view of the different distribution of lesions
in actively induced EAE compared to passively induced
EAE.
These differences in lesion distribution and clinical
signs in mice with actively induced EAE compared to
those with passively induced EAE are of particular inter-
est. EAE induced by PLP or MBP can be transferred by 
T cells alone. However, the differences we observe be-
tween passively induced EAE and actively induced EAE
suggest that some factor in actively immunized mice influ-
ences both the clinical signs and lesion distribution. A po-
tential candidate is PLP peptide-specific antibody, which
is present in high titer in all actively immunized mice, but
is undetectable in mice with passively transferred EAE
(Greer, unpublished data). Immunohistochemical studies
with cultured oligodendrocytes have shown that the orien-
tation of PLP in the myelin membrane is such that the
190–209 region of the molecule would lie on the external
face of the myelin membrane [10], and would therefore be
accessible to antibody attack. If the 190–209 region of
PLP in the cerebellum were more accessible to antibody
attack, this could account for the lesion distribution in ac-
tively induced EAE. Alternatively, anti-PLP antibody
might cross-react with some other cerebellar component,
such as the PLP homologue M6, which is expressed par-
ticularly strongly in the cerebellum [37].
This rotatory form of EAE may be a useful model for
studying MS. Firstly, the differences in clinical signs and
histology between active and passive disease suggest that
antibody is important. Secondly, this is a good model for
examining brain stem and cerebellar involvement in MS,
which is quite common [30], particularly in patients with
more advanced disease. Interestingly, we have recently
found that MS patients with relapsing-remitting or sec-
ondary progressive disease show increased T cell reactiv-
ity to the PLP190–209 peptide and an overlapping peptide
PLP184–199 [12]. This reactivity was particularly increased
in patients with a disease duration of between 5 and 
15 years. Tuohy et al. [35] also recently showed that two
out of three patients with anterior brain stem syndrome re-
sponded to PLP peptides within the 190–209 region. It is
interesting to speculate whether development of reactivity
to this region of PLP may predispose towards develop-
ment of lesions in these anatomical areas.
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